Shopping Cart
- Remove All
Your shopping cart is currently empty
PMMB-187, a selective STAT3 inhibitor, exhibits an IC50 of 1.81 μM in MDA-MB-231 cells. This compound induces apoptosis in MDA-MB-231 cells by inhibiting STAT3 transcriptional activity and nuclear translocation, reducing mitochondrial membrane potential, increasing reactive oxygen species (ROS) production, and upregulating the expression of apoptosis-related proteins. PMMB-187 is useful for research in the field of cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,930 | 8-10 weeks | |
| 50 mg | $4,110 | 8-10 weeks | |
| 100 mg | $4,630 | 8-10 weeks |
| Description | PMMB-187, a selective STAT3 inhibitor, exhibits an IC50 of 1.81 μM in MDA-MB-231 cells. This compound induces apoptosis in MDA-MB-231 cells by inhibiting STAT3 transcriptional activity and nuclear translocation, reducing mitochondrial membrane potential, increasing reactive oxygen species (ROS) production, and upregulating the expression of apoptosis-related proteins. PMMB-187 is useful for research in the field of cancer. |
| Targets&IC50 | STAT3:1.81 μM |
| Molecular Weight | 615.52 |
| Formula | C27H23BrN2O6S2 |
| Cas No. | 2162952-37-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.